Disease phenotype as a predictor of treatment response in osteoarthritis: results from a phase ii clinical trial of the first-in-class imidazoline-2 receptor ligand cr4056
OSTEOPOROSIS INTERNATIONAL(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要